About Gan & Lee Gan & Lee Pharmaceuticals developed the first Chinese domestic insulin analog. Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting ...

Since the start of 2024, Wockhardt’s stock price has almost tripled to Rs 1,233.85 per share as on November 8.

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Types of New Insulin Formulations: 1. Fast-acting insulin analogs: Faster onset, reduced hypoglycemia risk. 2.

While real paneer is rich in protein and calcium, analogue paneer typically contains harmful fats that can lead to ...

1,2 The findings of these studies suggest that administration of the long-acting analog insulin glargine increases the risk of cancer in patients with diabetes mellitus, whereas the biguanide ...

Gan & Lee was first among all companies in procurement demand for insulin analogs in China's 2024 National Insulin-Specific Centralized Procurement, the company said in the release.

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

The 2025 List of Prohibited Substances and Methods was approved by WADAâs Executive Committee (ExCo) during its meeting on 12 ...

GLP-1 medications, such as Ozempic, may interact with other drugs, causing very low blood sugar levels or disrupting the ...